ProCE Banner Activity

My Thoughts on IO in HNSCC Today

Clinical Thought

In this commentary from a live webinar, Dr Barbara Burtness describes utilization of immunotherapies early during treatment for relapsed or metastatic head and neck cancers.

Released: September 12, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Merck Sharp & Dohme, LLC

Merck Sharp & Dohme, LLC